Year: 2020

NeuBase Therapeutics’ CEO, Dietrich A. Stephan, Ph.D., to Present “Manufacturing Heat-Seeking Missiles Against Misbehaving Genes” at Tribe Public’s Event on October 28, 2020

ONCURIOUS I-O Portfolio Directed at Boosting T Cell Influx and Activity in Solid Tumors; Announcing First Preclinical Proof of Concept in Proprietary CCR8 Treg Program

- Strategic focus of immuno-oncology (I-O) portfolio on modulation of tumor microenvironment to enhance T cell influx and activity in immune...

error: Content is protected !!